Aims: To assess the therapeutic effect of curcumin supplementation in modulating the expression of NF-κB in the joints of collagen-induced arthritis (CIA) rats. 
INTRODUCTION
Curcumin, also known as diferuloylmethane, is a natural compound and principal curcuminoid of turmeric has been used in Indian Ayurvedic medicine for various diseases and ailments, besides culinary and textile use due to its characteristic yellow colour [1, 2] . There are overwhelming evidences on various properties of curcumin. The widely studied properties are anti-inflammatory, antioxidant and anticancer [2] . Thus, it has a potential against various inflammatory diseases, malignancy, allergies and other chronic illnesses. Curcumin has been extensively studied for its anti-inflammatory properties, and discovery of various pathways on how curcumin exert this effect have been found [3] [4] [5] [6] . One of them is through the inhibition of nuclear factor kappa B (NF-κB), transcription factor involved in inflammation [7] .
Nuclear factor kappa B (NF-κB) transcription factors are a family of structurally related eukaryotic transcription factors that promote the expression of well over 150 genes involved in a variety of cellular process [8] . Numerous studies have reported that the NF-κB proteins have diverse roles in B-cell development, proliferation, and effector functions, as well as proliferation of T-cell [9] . Synovial tissue, both human and several animal models of rheumatoid arthritis (RA0 have been shown to ubiquitously express NF-κB [10, 11] . One such animal model is collagen-induced arthritis (CIA).
Rheumatoid arthritis is one of the oldest known afflictions to mankind [12] and also the commonest form of chronic polyarthritis [13] . It is characterised as chronic, systemic inflammatory disorder that mainly attacks the joints, in addition to various other tissues and organs such as skin, blood vessels, heart, lungs and muscles [14] . A systematic review conducted in 2005 based on the 1987 American College of Rheumatology Criteria revealed that estimated prevalence of RA worldwide is between 0.2% and 1.2% [15] . Populationbased studies on epidemiology of RA are limited especially in the developing countries.
However, available evidence suggests that incidence of RA is skewing towards elderly age of onset and the incidence in women is on the rise. The mortality rate for the elderly population with RA is on the rise likely due to multi systemic manidestation of RA [16] . To date, the exact cause of RA has not been demonstrated. Studies have shown that the aetiology is multifactorial, which takes genetic factors [17] and environmental factors [18, 19] .
There is no cure for RA. Current treatment options focus improving the quality of life of a RA patient. Disease modifying anti-rheumatic drugs (DMARDs), biologics and non-steroidal antiinflammatory drugs (NSAIDs) are the frequently used therapeutics for the treatment of RA [20] . In spite of variety of treatment options available, a need for a safer and more efficient drug is still there. This is mainly due to the financial burden and side effects associated with current therapeutic option. Hence, the spotlight is being diverted toward natural compounds, which aid the boost of the "nutraceutical revolution".
NF-κB plays a substantial role in rheumatoid arthritis and has been under the spotlight as a new potential therapeutic target for the treatment of RA [11, 21] . Thus, we aim to assess the therapeutic effect of curcumin supplementation in modulating the expression of NF-κB in the joints of CIA rats.
MATERIALS AND METHODS

Experimental Animals
Female, Dark Agouti rats, were obtained at 6-10 weeks old from Institute of Medical Research (IMR), Malaysia and were acclimatized and maintained in Laboratory Animal House, International Medical University (IMU) under specific pathogen-free conditions. Each treatment group consisted of 6 rats.
Development of CIA
Collagen from chicken sternal cartilage Type II, Complete Freund's Adjuvant (CFA), Acetic Acid 99.8% was purchased from Sigma Aldrich, USA. Collagen induced arthritis was developed in the rats according to the protocol described by Brand et al. [22] . The type II collagen was reconstituted in 5 ml of 0.1M cold acetic acid and was added to the Complete Freund's Adjuvant (CFA) at a ratio of 1:1. The mixture was later homogenised for approximately 20 minutes at 4°C. Approximately 0.2 -0.4 ml emulsion was then injected intradermally at the rat's base of tail under general anaesthesia using diethyl ether. This amount the collagen-CFA emulsion injected was adjusted to the body weight of the rat on day 1 of arthritis induction. The optimum concentration of emulsion to be injected was previously determined through a pilot study conducted in International Medical University [23] .
Preparation and Administration of Treatments
Curcumin (>95%) was purchased from Natural Remedies, India, ≥99% crystalline Acetylsalicylic acid from Sigma Aldrich, USA. Curcumin was prepared in a standard vehicle of 0.5 -0.7 ml 100% olive oil. The amount administered was at concentrations of 500 mg/kg, 1000 mg/kg, 2000 mg/kg based on the weight of the rat at day 25 for arthritic groups. This dosage was selected based on previous established works [5] . As curcumin was delivered by oral gavage using a gavage tube, direct entry into the gastrointestinal surface was ensured. Moreover, the gavage was done on empty stomach before the actual feeding, hence ensuring optimum absorption without much wastage. Body weight is measured every 4 days and the dosage is changed accordingly for each rat during the treatment period. Appropriate quantities of curcumin were added to falcon tubes containing olive oil and thoroughly mixed using a sonicator ensuring both oil particles have combined to an even mixture. The compound was stored wrapped in aluminum foil, as it is light sensitive. Treatment was administered as oral supplementation daily using syringes without needle from day 25 to day 38 for 3 arthritic groups at the aforementioned concentrations respectively. Aspirin was similarly dissolved in water at a concentration of 3 mg/ml. Each rat received a dosage 25 mg/kg aspirin based on the weight at day 25 for arthritic group daily for 14 days. Body weight is measured every 4 days and the dosage is changed accordingly for each rat during the treatment period. Combination treatments were also administered to three arthritic groups; 500 mg/kg curcumin and 25 mg/kg aspirin; 1000 mg/kg curcumin and 25 mg/kg aspirin; 2000 mg/kg curcumin and 25 mg/kg aspirin from day 25 to 38. One noninduced group received only 0.5ml olive oil from day 25 to 38, and one arthritic group received 25 mg/kg aspirin, which were used as negative and positive control group.
Histological Examination
The knee joints of the rats were collected on day 39 of experimental cycle and were fixed in 10% formalin, decalcified, trimmed, and embedded. After sectioning, the slides were stained using haematoxylin and eosin staining. The slides were scored by a qualified pathologist based on these criteria; oedema, cellular infiltration, joint space, synovial hyperplasia, fibrosis and erosion (see Table 1 ). This grading system was developed by a previous study [24] .
Immunohistochemistry
The degree of inflammation in the rats was assessed using NF-κB levels in the knee joints. Rabbit polyclonal antibody to NF-κB p65 were purchased from ABCAM, UK. It was utilized to assess and grade the level of NF-κB in the knee joints through immunohistochemistry Table 1 .
Cytokines (TNF-α and IL-1β) and Gluthathione Peroxidase Levels
On the last day of the experimental cycle (day 39), blood samples were collected from the animals. After anesthetization with ether, approximately 3-5 ml of blood was obtained from each rat through cardiac puncture, resulting in its death. Tumour Necrosis Factor Alpha (TNF-α) and Interleukin -1 Beta (IL-1β) levels were quantified using the rat TNF-alpha Platinum ELISA kit (eBioscience, USA) and rat IL-1 beta Tissue Culture ELISA Ready-SETGo!® kit (Cayman Chemical, USA) respectively. Gluthathione Peroxidase assay kit (Cayman Chemical, USA) was used to quantify the Gluthathione Peroxidase (GPx) levels. All the procedures were followed according to the respective manufacturer's protocol.
Statistical Analysis
All data was analysed using SPSS v.18 (SPSS Inc, Chicago, IL, USA). Mann Whitney U test for nonparametric data was used to analyse the arthritic scores and NF-κB expression. Data from ELISA was analysed using one-way ANOVA followed by Tukey's test. For all the tests, p = 0.05 was considered to be significant. One day following the induction of CIA, the physical activity level of the rats decreased. On day 7 after induction, the swelling of the knee joint started and reached its peak on day 21. The rats started to limp or drag both its hind paws while moving by day 21. On histological examination of the knee joint, the non-induced group (vehicle) exhibited no signs of inflammatory changes. However, the arthritis (vehicle) and arthritis + 500 mg/kg curcumin group exhibited all signs of inflammation (oedema, inflammatory cell infiltration, joint space narrowing, snynovial hyperplasia, fibrosis and erosion). Similar findings were found in arthritis (vehicle) group (p>0.05). Interestingly, arthritis + 1000 mg/kg curcumin, arthritis + 2000 mg/kg curcumin and arthritis + 25 mg/kg aspirin all exhibited reduced inflammatory features and signs of healing (p<0.01). Combination treatment groups which are arthritis + 500 mg/kg curcumin + 25 mg/kg aspirin, arthritis + 1000 mg/kg curcumin + 25 mg/kg aspirin and arthritis + 2000 mg/kg curcumin + 25 mg/kg aspirin group showed reduced inflammation and healing when compared to arthritis (vehicle) group (p<0.05). When curcumin alone treated groups (500 mg/kg, 1000 mg/kg, 2000 mg/kg) and combination treatment groups compared with arthritis + 25 mg/kg aspirin group, there were no significant difference found in terms of inflammatory features (p>0.05) on histology examination. As seen in Fig. 2 , the NF-κB expression in the arthritis (vehicle) group was significantly higher than the non-induced (vehicle) group (p<0.01). Significant reduction in NF-κB expression was observed in arthritis + 25 mg/kg aspirin (p<0.01), arthritis + 1000 mg/kg curcumin (p<0.01) and arthritis + 2000 mg/kg curcumin (p<0.01) groups when compared with arthritis (vehicle) group. Significant reduction of NF-κB was found in all the combination treatment groups when compared to the arthritis (vehicle) group (p<0.01). Comparison were also made between arthritis + 25 mg/kg aspirin and all the combination treatment groups, which revealed good correlation (p<0.01) except in arthritis + 500 mg/kg curcumin + 25 mg/kg aspirin group (p<0.05).
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A very similar pattern was seen in term of IL-1β expression as well. The arthritis (vehicle) group expressed significantly higher levels of IL-1β compared to non-induced (vehicle) group (p=0.05). However, only significant reduction of IL-1β levels were only seen in arthritis + 1000 mg/kg curcumin and arthritis + 2000 mg/kg curcumin groups (p=0.05). In the combination treatment groups, arthritis + 1000 mg/kg curcumin + 25 mg/kg aspirin and arthritis + 2000 mg/kg curcumin + 25 mg/kg aspirin groups expressed significantly lower levels of IL-1β levels compared to the arthritis + 25 mg/kg aspirin group (p=0.05).
Gluthathione Peroxidase Activity Level
Gluthathione peroxidase levels was significantly higher in the non-induced (vehicle) group in comparison to all other groups (p=0.05). Nonetheless, arthritis + 500 mg/kg curcumin, arthritis + 1000 mg/kg curcumin and arthritis + 2000 mg/kg curcumin showed significant increase in GPx level when compared to the arthritis (vehicle) group (p=0.05). Similarly, all the combination treatments groups showed significant increase when compared to the same group (p=0.05). Only arthritis + 2000 mg/kg curcumin + 25 mg/kg aspirin group showed significant increase in GPx level when compared to arthritis + 25 mg/kg aspirin group (p=0.05).
This study was done to observe the effect of curcumin in arthritis and also its relationship with the function of NF-κB. Curcumin has been widely used as a therapeutic agent in traditional medicine for several centuries. Scientific studies on role of curcumin in health related conditions are fairly new in the research world. Much of the research in curcumin has been focused in areas like, cancer, wound healing, malaria and just to name a few [25] .
Effect of curcumin in arthritis has not been studied much except for a few research works which have highlighted the role of curcumin in arthritis. Mun et al. demonstrated that oral administration of curcumin ameliorates type II collagen-induced arthritis in mice. They also reported that it inhibits the production of matrix metalloproteinase-1 and matrix mettaloproteinase III production in CIA is mediated through the inhibition of protein kinase Cδ (PKCδ) and the JNK/c-Jun signaling pathway [26] .
Rheumatoid arthritis involves several cytokines in its pathogenesis. However, TNF-α is considered to be at the apex of of cytokine cascade that lead to pathological changes in RA. Development of anti TNF-α therapy has been successful in disease remission to a certain extent [14, 15] . Interleukin-1β is another main cytokines that contribute to the disease progression and therapy against this cytokine has been proven effective [15, 16] . Oxidative damage by free oxygen radical has been associated in the pathobiology of rheumatoid arthritis. Glutathione peroxidase dependent mechanism is one of the pathway erythrocyte utilized to scavenge free oxygen radical, in order to minimize the extent of damage to tissue [17] .
On another study conducted by Okamoto et al., similar finding was reported, through inhibition of Interleukin-17 (IL-17) [27] . Recently, a clinical trial was carried out by Chandran et al. on the efficacy and safety of curcumin on active rheumatoid arthritis patients, which was then proven to be more effective than diclofenac sodium, an established antiinflammatory. No adverse events was reported [28] . Hence, it is justifiable to study its effect in management of rheumatoid arthritis [29] . The role of NF-κB in arthritis is an established one. It has proinflammatory properties and is expected to increase the level of inflammation and hence, would be expected in high concentration when there is arthritis, whether the arthritis is an active form of disease or whether there is a certain amount of healing [30] . Therefore, the level of NF-κB would vary depending on the tissues in the joints in normal, inflammatory, healing, and healed tissue.
Nuclear factor kappa-B in arthritis has been studied extensively, some of which have been referred to in this study. Yamasaki et al. proved that NF-κB is highly expressed in synovial tissue from rheumatoid arthritis patients [31] . Inhibitor of nuclear factor kappa B kinase (IKKβ) activation, causes the NF-κB translocation into the nucleus to initiate inflammatory response. This was demonstrated in Lewis rats by Tak et al [32] . To further clarify the role of NF-κB, Tsuchiya et al., proved that inhibition of translocation of NF-κB to the nucleus resulted in reduction of cytokines production that is involved in rheumatoid arthritis [33, 34] .
In the histopathology study, there were no morphological changes in the non-induced + vehicle group. However, in the arthritis (vehicle) and arthritis + 500 mg/kg curcumin, there was extensive damage to the joint including oedema, inflammatory cell infiltrates, joint space narrowing, synovial hyperplasia, fibrosis and bone erosion. This difference was significant (p<0.05) when compared to the control group.
Observation on the arthritis + 1000 mg/kg curcumin, arthritis + 2000 mg/kg curcumin and all combination treatment groups and arthritis + 25 mg/kg aspirin showed a significant reduction in pathology and also areas of healing as suggested by the presence of granulation tissue which is seen as proliferation of small blood vessels and fibroblast. Our histopathological changes due to curcumin at higher doses treatment after induction of arthritis were comparable to studies done. [26, 35] .
Non-induced group (vehicle) showed nil or scattered expression of NF-κB. Over expression of NF-κB was seen in arthritis (vehicle) and arthritis + 500 mg/kg curcumin. Arthritis + 1000 mg/kg curcumin, arthritis + 2000 mg/kg curcumin, arthritis + 25 mg/kg aspirin and all combination treatment groups showed low to moderate expression. Combination group of 1000 mg/kg curcumin and 2000 mg/kg curcumin together 25 mg/kg aspirin, showed significant result when compared to aspirin treated arthritic group (p<0.05).
In short, inflammatory response was lower at higher doses of curcumin, and it was even better when given together with aspirin. Several studies have documented inhibition of NF-κB by curcumin, but only in cell line by Singh et al. [7] .
Both TNF-α and IL-1β levels were found to be increased in the arthritis groups and comparatively decreased in all the treated groups with more prominent reduction observed as curcumin dosages increased, along with aspirin. It was even more reduced in combination treatment groups.
Glutathione peroxidase was found to be decreased in the arthritis (vehicle) and arthritis + 500 mg/kg curcumin groups and showed increasing levels in the healing groups and this were comparable to negative control group. Combination group again showed higher levels of GPx than aspirin treated arthritic group. These reduction of TNF-α and IL-1β and increase in GPx level in amelioration of CIA due to treatment were consistent with several other studies [36, 37] .
Based on these findings, curcumin given after arthritis in high doses, shows effects of healing and this results were comparable to positive control group, which is the arthritic group treated with 25 mg/kg aspirin. Curcumin given in combination with aspirin, showed better reduction in pathology in arthritic group compared to positive control group, especially with higher doses of curcumin.
CONCLUSION
In this study, curcumin has been found to have a therapeutic effect in the treatment of CIA in DA rats, however only at higher doses. The action of curcumin has an inverse proportional relationship with NF-κB expression as observed in other studies. It also shows that combination treatment of aspirin and curcumin is beneficial in CIA, which need further research including clinical trials. This can bring about major changed in the treatment of rheumatoid arthritis with fewer side effects that is currently through the use of natural compounds like curcumin.
For future study, this therapeutic effect of curcumin on the expression of NF-κB in CIA may be reaffirmed by real time polymerase chain reaction (q-PCR) method. In the next level of animal study, curcumin can be compared to a primary anti-rheumatic drug, such as methotrexate to further assess its therapeutic efficacy.
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